|
|
3132 Kashiwa Street
Torrance, CA 90505 USA
phone:+1 888 422 2436
fax:+1 310 539 9428
|
|
| Symbol |
BANB |
| Exchange |
SWX |
| Founded |
1971 |
| Employees |
|
|
|
| www.bachem.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Production of biochemical and pharmaceutical compounds. |
|
| Management |
| Dr. Thomas Fruh, Executive Vice President and COO Bachem AG, Switzerland; Philip Ottiger, President and CEO Bachem Americas, Inc., USA; Dr. Alex Fssler, President and COO Bachem, Inc., USA; Dr. Mike Pennington, President and COO Bachem Bioscience, Inc., USA; Dr. Damir Vidovic, President and COO Peninsula Laboratories, LLC, USA |
| |
|
|
|
|
|
|
|
| Keywords |
| immunology, glucagon, oxyntomodulin, cetrorelix, methylalkanamides |
|
|
|
| Description |
|
Bachem is an independent, technology-based company specializing in the production of innovative biochemical and pharmaceutical compounds. |
|
| Products / Services |
Research chemicals, amino acid derivatives, organic compounds, peptides, new chemical entities, generic APIs, custom Synthesis, immunochemicals and custom immunology services.
|
|
| Technology / Differentiation |
| Bachem is the world's sole peptide "full service provider", comprising: 6 production sites with more than 15 buildings in the U.S. and in Europe; Full cGMP manufacturing and research level production (both in the U.S. and Europe); Capacity ranges from milligram amounts for preclinical work up to hundreds of kilograms of active pharmaceutical ingredients (APIs) and tons of key intermediates; Manufacturing of peptidic and non-peptidic cytotoxic and cytostatic compounds; Production and release of finished dosage forms. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
